Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1206-1212
Published online before print April 7, 2005, doi: 10.1161/01.ATV.0000164805.73558.80
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v25,pe128)
Right arrow All Versions of this Article:
25/6/1206    most recent
01.ATV.0000164805.73558.80v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robbesyn, F.
Right arrow Articles by Salvayre, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robbesyn, F.
Right arrow Articles by Salvayre, R.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Cell signalling/signal transduction
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1206.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

High-Density Lipoproteins Prevent the Oxidized Low-Density Lipoprotein–Induced Endothelial Growth Factor Receptor Activation and Subsequent Matrix Metalloproteinase-2 Upregulation

Fanny Robbesyn; Nathalie Augé; Cécile Vindis; Anne-Valérie Cantero; Ronald Barbaras; Anne Negre-Salvayre; Robert Salvayre

From INSERM U-466 and Biochimie IFR-31 (F.R., N.A., C.V., A.-V.C., A.N.-S., R.S.), Faculty of Medicine, University Paul Sabatier, Toulouse, France; INSERM U-563 (R.B.), Centre de Physiopathologie de Toulouse-Purpan, Department Lipoproteines et Mediateurs Lipidiques, IFR-30, Toulouse, France.

Correspondence to R. Salvayre or A. Negre-Salvayre, Biochimie, INSERM U466, IFR-31, CHU Rangueil, 1, avenue Jean Poulhès, TSA-50032, 31059 Toulouse Cedex 9, France. E-mail salvayre{at}toulouse.inserm.fr or anesalv@toulouse.inserm.fr

Objectives— The atherogenic oxidized low-density lipoprotein (oxLDL) induces the formation of carbonyl-protein adducts and activates the endothelial growth factor receptor (EGFR) signaling pathway, which is now regarded as a central element for signal transduction. We aimed to investigate whether and by which mechanism the anti-atherogenic high-density lipoprotein (HDL) prevents these effects of oxLDL.

Methods and Results— In vascular cultured cells, HDL and apolipoprotein A-I inhibit oxLDL-induced EGFR activation and subsequent signaling by acting through 2 separate mechanisms. First, HDL, like the aldehyde scavenger dinitrophenyl hydrazine, prevented the formation of oxLDL-induced carbonyl–protein adducts and 4-hydroxynonenal (HNE)–EGFR adducts. Secondly, HDL enhanced the cellular antioxidant defenses by preventing (through a scavenger receptor class B-1 (SR-BI)–dependent mechanism) the increase of intracellular reactive oxygen species (ROS) and subsequent EGFR activation triggered by oxLDL or H2O2. A pharmacological approach suggests that this protective effect of HDL is independent of cellular glutathione level and glutathione peroxidase activity, but it requires catalase activity. Finally, we report that oxLDL upregulates both membrane type 1 (MT1)-matrix metalloproteinase-1 (MT1-MMP) and MMP-2 through an EGFR-dependent mechanism and that HDL inhibits these events.

Conclusions— HDLs block in vitro oxLDL-induced EGFR signaling and subsequent MMP-2 activation by inhibiting carbonyl adducts formation and cellular oxidative stress. These effects of HDL may participate to reduce cell activation, excessive remodeling, and alteration of the vascular wall.

Oxidized LDLs induce EGFR activation and subsequent MMP-2 activation. HDLs inhibit these events by 2 separate mechanisms, ie, by blocking carbonyl–protein adduct formation and by inhibiting the oxLDL-induced and H2O2-induced intracellular ROS increase, through a catalase-dependent process. This may contribute to reduce cell activation, excessive remodeling, and vascular wall alteration.


Key Words: atherosclerosis • endothelial growth factors • lipoproteins




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
R. Simo, M. Higuera, M. Garcia-Ramirez, F. Canals, J. Garcia-Arumi, and C. Hernandez
Elevation of Apolipoprotein A-I and Apolipoprotein H Levels in the Vitreous Fluid and Overexpression in the Retina of Diabetic Patients
Arch Ophthalmol, August 1, 2008; 126(8): 1076 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X. W. Cheng, T. Murohara, M. Kuzuya, H. Izawa, T. Sasaki, K. Obata, K. Nagata, T. Nishizawa, M. Kobayashi, T. Yamada, et al.
Superoxide-Dependent Cathepsin Activation Is Associated with Hypertensive Myocardial Remodeling and Represents a Target for Angiotensin II Type 1 Receptor Blocker Treatment
Am. J. Pathol., August 1, 2008; 173(2): 358 - 369.
[Abstract] [Full Text] [PDF]